Raizy Klahr
Medical · Suffern, NYNPI 1932389848
Payments from drug & device makers
Across 602 payments — averaging $21.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$1K
- Regeneron Healthcare Solutions, Inc.$1K
- CSL Behring$1K
- Sanofi$922
- Biocryst US Sales Co., LLC$807
- plus $5K from 29 others
What the payments were for
- Food & beverage$12,66897%
- Education$3503%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 83 | $2,387 |
| GSK | 91 | $1,285 |
| Regeneron Healthcare Solutions, Inc. | 32 | $1,131 |
| CSL Behring | 49 | $1,087 |
| Sanofi | 33 | $922 |
| Biocryst US Sales Co., LLC | 47 | $807 |
| Genentech USA, Inc. | 41 | $598 |
| Novartis | 37 | $549 |
| Kaleo, Inc. | 27 | $546 |
| Amgen(2 entities) | 25 | $419 |
| Takeda Pharmaceuticals U.S.A., Inc. | 14 | $337 |
| Pharming Healthcare, Inc. | 15 | $324 |
| Pfizer | 13 | $282 |
| Blueprint Medicines Corporation | 7 | $265 |
| Grifols USA, LLC | 12 | $226 |
| Incyte Corporation | 5 | $204 |
| Optinose US, Inc. | 11 | $193 |
| Ionis Pharmaceuticals, Inc. | 13 | $175 |
| Galderma Laboratories, L.p. | 2 | $171 |
| Boehringer Ingelheim | 8 | $161 |
| Covis Pharma GmbH | 9 | $154 |
| Alk-abello, Inc | 7 | $129 |
| Dermavant Sciences, Inc. | 1 | $126 |
| Novo Nordisk | 1 | $125 |
| Cycle Pharmaceuticals Inc | 4 | $104 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $61 |
| Merck | 4 | $60 |
| Sanofi-aventis U.S. LLC | 1 | $60 |
| Seqirus USA Inc | 1 | $24 |
| Aimmune Therapeutics, Inc. | 1 | $23 |
| LEO Pharma Inc. | 1 | $21 |
| Phadia US Inc. | 1 | $17 |
| Viatris Specialty LLC | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$13,018 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Breo ElliptaFluticasone/Vilanterol | 24 | $14,725 |
| Spiriva RespimatTiotropium Bromide | 12 | $9,904 |
| Arnuity ElliptaFluticasone Furoate | 11 | $5,952 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 26 | $5,350 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $3,430 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 16 | $1,699 |
| Levocetirizine Dihydrochloride | 63 | $997 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 37 | $945 |
| Fluticasone Propionate | 33 | $843 |
| Ventolin HfaAlbuterol Sulfate | 12 | $666 |
| Azelastine Hcl | 19 | $589 |
| Montelukast Sodium | 50 | $247 |
| Omeprazole | 11 | $223 |
| Triamcinolone Acetonide | 11 | $104 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKBreo Ellipta, Arnuity Ellipta | $1,285 | $20,67735 claims |
| Boehringer IngelheimSpiriva Respimat | $161 | $9,90412 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,395 medical providers in New York.
Other medical in Suffern
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.